Ardent Health director granted 14,231 RSUs

Sotir Mark R reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Sotir Mark R reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. director and Chair of the Board Mark R. Sotir received an award of 14,231 shares of Common Stock in the form of restricted stock units at no purchase price. These units vest in full on the first anniversary of April 1, 2026, contingent on his continued service with the company. Following this grant, he holds 38,709 shares directly.

Insider Trade Summary

Grant/Award: 14,231 shares

Grant/Award 1 txn

Insider Sotir Mark R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,231	$0.00	$0.00

Holdings After Transaction: Common Stock — 38,709 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Key Figures

RSU grant size: 14,231 shares Grant price per share: $0.00 per share Shares held after grant: 38,709 shares

3 metrics

RSU grant size 14,231 shares Restricted stock units of Common Stock granted to Mark R. Sotir

Grant price per share $0.00 per share Reported transaction price for the RSU award

Shares held after grant 38,709 shares Direct holdings of Mark R. Sotir following the transaction

Key Terms

restricted stock units, vesting, Common Stock, grant, award, or other acquisition

4 terms

restricted stock units financial

"Represents restricted stock units that vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"units that vest in full on the first anniversary of April 1, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ardent Health (ARDT) report for Mark R. Sotir?

Ardent Health reported that director and Chair of the Board Mark R. Sotir received a grant of 14,231 restricted stock units of Common Stock. The award was recorded as an acquisition at no purchase price and increases his directly held shares to 38,709.

How many Ardent Health (ARDT) shares were granted to Mark R. Sotir?

Mark R. Sotir was granted 14,231 restricted stock units representing shares of Ardent Health Common Stock. These units are a form of equity compensation and will convert into shares only if the specified vesting condition tied to his continued service is satisfied.

When do Mark R. Sotir’s Ardent Health (ARDT) restricted stock units vest?

The restricted stock units granted to Mark R. Sotir vest in full on the first anniversary of April 1, 2026. Vesting is conditioned on his continued service with Ardent Health through that vesting date, meaning the units must be held until then to settle into shares.

What is Mark R. Sotir’s Ardent Health (ARDT) share ownership after this Form 4?

After the reported grant, Mark R. Sotir directly holds 38,709 shares of Ardent Health Common Stock. This figure reflects his position following the acquisition of 14,231 restricted stock units recorded in the filing, highlighting his ongoing equity stake as Chair of the Board.

Did Mark R. Sotir buy or sell Ardent Health (ARDT) shares in this filing?

The filing shows no open-market buy or sell. Instead, Mark R. Sotir received 14,231 restricted stock units as a grant categorized as a “grant, award, or other acquisition,” with a reported price per share of zero, typical for equity compensation.

What conditions apply to Mark R. Sotir’s Ardent Health (ARDT) equity grant?

The restricted stock units vest only if Mark R. Sotir continues serving Ardent Health through the vesting date, the first anniversary of April 1, 2026. If he remains in service, the RSUs are scheduled to vest in full and convert into Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:50 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sotir Mark R

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Chair of the Board

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		14,231(1)	A	$0	38,709	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)